Institut Claudius Regaud
Clinical trials sponsored by Institut Claudius Regaud, explained in plain language.
-
New scan aims to pinpoint hidden thyroid cancer
Diagnosis CompletedThis study tested a new type of PET scan to see if it could better find leftover thyroid cancer cells in patients who still had signs of disease after surgery. Researchers compared the new scan to standard imaging tests in 24 patients to see which method was more accurate at loca…
Phase: NA • Sponsor: Institut Claudius Regaud • Aim: Diagnosis
Last updated Mar 25, 2026 14:07 UTC
-
Scientists create detailed map of lymphoma to predict treatment success
Knowledge-focused CompletedThis study aims to create a detailed map of immune and cancer cells in patients with diffuse large B-cell lymphoma. Researchers will follow 60 patients receiving standard R-CHOP treatment for two years, analyzing blood and tumor samples to identify biomarkers that could predict t…
Phase: NA • Sponsor: Institut Claudius Regaud • Aim: Knowledge-focused
Last updated Mar 30, 2026 14:35 UTC
-
Scientists probe body Clock's role in cancer spread
Knowledge-focused CompletedThis study aimed to understand if the body's natural daily rhythm (circadian rhythm) influences how lung cancer cells spread through the bloodstream. It followed 27 patients with advanced lung cancer for one year, taking blood samples before they started treatment. The goal was t…
Phase: NA • Sponsor: Institut Claudius Regaud • Aim: Knowledge-focused
Last updated Mar 30, 2026 14:34 UTC
-
Scientists hunt mysterious cells in cancer Patients' blood
Knowledge-focused CompletedThis study aimed to understand whether certain unusual cells found in the blood of people with metastatic breast cancer actually come from their tumors. Researchers collected blood samples from 60 patients before they started new cancer treatments to analyze these cells. The goal…
Phase: NA • Sponsor: Institut Claudius Regaud • Aim: Knowledge-focused
Last updated Mar 16, 2026 15:27 UTC